News

Events, Buildings in Teal Marking Alzheimer’s Awareness Month

From sporting teal to getting a virtual memory screening, supporters across the U.S. are marking National Alzheimer’s Awareness Month, observed each November, to call attention to the progressive neurodegenerative disorder and the 6.2 million people it’s thought to affect. The Alzheimer’s Foundation of America (AFA) is offering a…

Lecanemab Slows Dementia of Early Alzheimer’s in Phase 3 Trial

Treatment with lecanemab (BAN2401), an experimental amyloid-targeting antibody, significantly slowed the progression of dementia symptoms among people with early Alzheimer’s disease in the Phase 3 Clarity AD clinical trial, Biogen and Eisai announced. Both companies, the therapy’s developers, plan to discuss these results with regulatory authorities in the U.S.,…